Bio-Techne (TECH) Interest Coverage Ratio Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.03% |
| Dec 31, 2025 | 12.02% |
| Sep 30, 2025 | 7.88% |
| Jun 30, 2025 | -26.87% |
| Mar 31, 2025 | 12.60% |
| Dec 31, 2024 | 23.80% |
| Sep 30, 2024 | 23.55% |
| Jun 30, 2024 | 18.75% |
| Mar 31, 2024 | 14.17% |
| Dec 31, 2023 | 8.51% |
| Sep 30, 2023 | 18.35% |
| Jun 30, 2023 | 37.67% |
| Mar 31, 2023 | 28.37% |
| Dec 31, 2022 | 22.70% |
| Sep 30, 2022 | 5.07% |
| Jun 30, 2022 | 11.65% |
| Mar 31, 2022 | -37.80% |
| Dec 31, 2021 | -36.49% |
| Sep 30, 2021 | -48.49% |
| Jun 30, 2021 | -25.76% |
| Mar 31, 2021 | -23.29% |
| Dec 31, 2020 | -30.86% |
| Sep 30, 2020 | -30.55% |
| Jun 30, 2020 | -38.58% |
| Mar 31, 2020 | -35.47% |
| Dec 31, 2019 | -37.42% |
| Sep 30, 2019 | -43.74% |